Mogamulizumab for Treatment of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-Based Series.

Eric A MeyerowitzShibani S MukerjiG Kyle HarroldRachel M ErdilSteven T ChenEmily A RudmannAthe TsibrisNagagopal VennaGregory K Robbins

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

Clinical trials are needed including diverse patient populations to assess the potential role of MOG for HAM/TSP. Our findings may help inform the development of these trials.

Keyphrases

clinical trial
spinal cord
climate change
cerebral palsy
human health
risk assessment
spinal cord injury
botulinum toxin
open label
upper limb
phase ii
replacement therapy